Galera Therapeutics Inc (GRTX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: GRTX Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-02-26 2024-02-08 B Purchase

Schneid Yair

Major owner
150,000 +1.9%
0.17
25,650 USD 		150,000 +1.9% 0.17 25,650 USD
2024-02-26 2024-02-07 B Purchase

Schneid Yair

Major owner
150,000 +1.9%
0.17
25,935 USD 		150,000 +1.9% 0.17 25,935 USD
2024-02-26 2024-02-07 B Purchase

Schneid Yair

Major owner
25,000 +0.3%
0.17
4,250 USD 		25,000 +0.3% 0.17 4,250 USD
2024-02-26 2024-02-06 B Purchase

Schneid Yair

Major owner
25,000 +0.3%
0.20
5,025 USD 		25,000 +0.3% 0.20 5,025 USD
2024-02-26 2024-02-05 B Purchase

Schneid Yair

Major owner
97,402 +1.3%
0.18
17,922 USD 		97,402 +1.3% 0.18 17,922 USD
2024-02-26 2024-01-30 B Purchase

Schneid Yair

Major owner
335,000 +4.6%
0.18
60,635 USD 		335,000 +4.6% 0.18 60,635 USD
2024-02-26 2024-01-29 B Purchase

Schneid Yair

Major owner
150,000 +2.1%
0.18
27,000 USD 		150,000 +2.1% 0.18 27,000 USD
2023-03-20 2023-03-16 B Purchase

Bachleda Mark

Chief Commercial Officer

Officer
11,000 +inf%
2.25
24,717 USD 		11,000 +inf% 2.25 24,717 USD
2023-03-14 2023-03-13 B Purchase

Degnan Chris

Chief Financial Officer

Officer
10,000 +inf%
1.96
19,593 USD 		10,000 +inf% 1.96 19,593 USD
2023-03-14 2023-03-10 B Purchase

Sorensen Mel

President and CEO

Executive Director
100,000 +43.1%
1.68
168,120 USD 		100,000 +43.1% 1.68 168,120 USD
2021-12-20 2021-12-17 B Purchase

West Linda

Non-Executive Director
20,000 +50.0%
2.74
54,804 USD 		20,000 +50.0% 2.74 54,804 USD
2021-09-03 2021-09-01 PS Planned sale

HOLMLUND JON T

Chief Medical Officer

Officer
47,756 -100.0%
8.47
404,498 USD 		47,756 -100.0% 8.47 404,498 USD
2021-06-17 2021-06-15 B Purchase

West Linda

Non-Executive Director
10,000 +33.3%
9.13
91,300 USD 		10,000 +33.3% 9.13 91,300 USD
2021-06-04 2021-06-02 B Purchase

West Linda

Non-Executive Director
10,000 +50.0%
8.65
86,511 USD 		10,000 +50.0% 8.65 86,511 USD
2021-06-03 2021-06-01 B Purchase

Alleva Lawrence M

Non-Executive Director
4,045 +inf%
8.59
34,741 USD 		4,045 +inf% 8.59 34,741 USD
2021-06-02 2021-06-01 B Purchase

West Linda

Non-Executive Director
10,000 +100.0%
8.64
86,381 USD 		10,000 +100.0% 8.64 86,381 USD
2021-06-02 2021-05-28 B Purchase

West Linda

Non-Executive Director
10,000 +inf%
8.64
86,410 USD 		10,000 +inf% 8.64 86,410 USD
2021-02-19 2021-02-18 S Sale

Novo Holdings A/S

Major owner
500,000 -16.9%
10.58
5,290,000 USD 		500,000 -16.9% 10.58 5,290,000 USD
2020-11-17 2020-11-13 B Purchase

Alleva Lawrence M

Non-Executive Director
2,325 +58.1%
10.22
23,771 USD 		2,325 +58.1% 10.22 23,771 USD
2020-11-16 2020-11-13 S Sale

Sussman Joel F.

Chief Accounting Officer

Officer
10,000 -100.0%
10.32
103,197 USD 		10,000 -100.0% 10.32 103,197 USD
2020-11-16 2020-11-12 S Sale

Sussman Joel F.

Chief Accounting Officer

Officer
10,000 -100.0%
10.06
100,627 USD 		10,000 -100.0% 10.06 100,627 USD
2020-10-28 2020-10-26 PS Planned sale

HOLMLUND JON T

Chief Medical Officer

Officer
2,244 -100.0%
15.00
33,660 USD 		2,244 -100.0% 15.00 33,660 USD
2020-10-19 2020-10-15 S Sale

Novo Holdings A/S

Major owner
450,000 -13.2%
11.00
4,950,000 USD 		450,000 -13.2% 11.00 4,950,000 USD
2020-10-07 2020-10-06 PS Planned sale

HOLMLUND JON T

Chief Medical Officer

Officer
10,536 -100.0%
12.00
126,432 USD 		10,536 -100.0% 12.00 126,432 USD
2020-10-07 2020-10-05 PS Planned sale

HOLMLUND JON T

Chief Medical Officer

Officer
100 -100.0%
12.00
1,200 USD 		100 -100.0% 12.00 1,200 USD
2020-06-22 2020-06-19 S Sale

Novartis Bioventures Ltd

Former 10% Owner
1,001,312 -28.9%
8.25
8,260,824 USD 		1,001,312 -28.9% 8.25 8,260,824 USD
2020-06-22 2020-06-18 S Sale

Novartis Bioventures Ltd

Former 10% Owner
900 -0.0%
9.04
8,136 USD 		900 -0.0% 9.04 8,136 USD
2020-06-17 2020-06-17 S Sale

Novartis Bioventures Ltd

Major owner
4,622 -0.1%
9.27
42,846 USD 		4,622 -0.1% 9.27 42,846 USD
2020-06-17 2020-06-16 S Sale

Novartis Bioventures Ltd

Major owner
8,600 -0.2%
9.30
79,980 USD 		8,600 -0.2% 9.30 79,980 USD
2020-06-17 2020-06-15 S Sale

Novartis Bioventures Ltd

Major owner
6,164 -0.2%
9.05
55,784 USD 		6,164 -0.2% 9.05 55,784 USD
2020-06-12 2020-06-12 S Sale

Novartis Bioventures Ltd

Major owner
1,500 -0.0%
9.19
13,785 USD 		1,500 -0.0% 9.19 13,785 USD
2020-06-12 2020-06-11 S Sale

Novartis Bioventures Ltd

Major owner
7,200 -0.2%
9.21
66,312 USD 		7,200 -0.2% 9.21 66,312 USD
2020-06-12 2020-06-10 S Sale

Novartis Bioventures Ltd

Major owner
8,532 -0.2%
9.46
80,713 USD 		8,532 -0.2% 9.46 80,713 USD
2020-06-09 2020-06-09 S Sale

Novartis Bioventures Ltd

Major owner
7,000 -0.2%
9.38
65,660 USD 		7,000 -0.2% 9.38 65,660 USD
2020-06-09 2020-06-08 S Sale

Novartis Bioventures Ltd

Major owner
5,659 -0.2%
9.66
54,666 USD 		5,659 -0.2% 9.66 54,666 USD
2020-06-09 2020-06-05 S Sale

Novartis Bioventures Ltd

Major owner
8,652 -0.2%
9.66
83,578 USD 		8,652 -0.2% 9.66 83,578 USD
2020-06-04 2020-06-04 S Sale

Novartis Bioventures Ltd

Major owner
4,088 -0.1%
9.55
39,040 USD 		4,088 -0.1% 9.55 39,040 USD
2020-06-04 2020-06-03 S Sale

Novartis Bioventures Ltd

Major owner
5,208 -0.1%
9.78
50,934 USD 		5,208 -0.1% 9.78 50,934 USD
2020-06-04 2020-06-02 S Sale

Novartis Bioventures Ltd

Major owner
5,669 -0.2%
9.68
54,876 USD 		5,669 -0.2% 9.68 54,876 USD
2020-05-28 2020-05-26 PS Planned sale

HOLMLUND JON T

Chief Medical Officer

Officer
692 -100.0%
12.00
8,304 USD 		692 -100.0% 12.00 8,304 USD
2020-05-22 2020-05-21 PS Planned sale

HOLMLUND JON T

Chief Medical Officer

Officer
1,174 -100.0%
12.00
14,088 USD 		1,174 -100.0% 12.00 14,088 USD
2020-05-22 2020-05-20 PS Planned sale

HOLMLUND JON T

Chief Medical Officer

Officer
969 -100.0%
12.00
11,628 USD 		969 -100.0% 12.00 11,628 USD
2020-05-12 2020-05-12 PS Planned sale

HOLMLUND JON T

Chief Medical Officer

Officer
671 -100.0%
12.00
8,052 USD 		671 -100.0% 12.00 8,052 USD
2020-05-12 2020-05-11 PS Planned sale

HOLMLUND JON T

Chief Medical Officer

Officer
185 -100.0%
12.00
2,220 USD 		185 -100.0% 12.00 2,220 USD
2020-05-12 2020-05-08 PS Planned sale

HOLMLUND JON T

Chief Medical Officer

Officer
5,102 -100.0%
12.00
61,224 USD 		5,102 -100.0% 12.00 61,224 USD
2020-05-07 2020-05-07 PS Planned sale

HOLMLUND JON T

Chief Medical Officer

Officer
2,059 -100.0%
12.00
24,709 USD 		2,059 -100.0% 12.00 24,709 USD
2020-05-07 2020-05-06 PS Planned sale

HOLMLUND JON T

Chief Medical Officer

Officer
1,489 -100.0%
12.00
17,868 USD 		1,489 -100.0% 12.00 17,868 USD
2020-05-07 2020-05-05 PS Planned sale

HOLMLUND JON T

Chief Medical Officer

Officer
3,064 -100.0%
12.16
37,258 USD 		3,064 -100.0% 12.16 37,258 USD
2019-12-17 2019-12-13 B Purchase

Alleva Lawrence M

Non-Executive Director
4,000 +inf%
9.78
39,139 USD 		4,000 +inf% 9.78 39,139 USD
2019-11-14 2019-11-12 B Purchase

Clarus IV-A, L.P.

Major owner
19,423 +17.5%
12.00
233,076 USD 		19,423 +17.5% 12.00 233,076 USD
2019-11-14 2019-11-12 B Purchase

Clarus IV-A, L.P.

Major owner
97,131 +17.5%
12.00
1,165,572 USD 		97,131 +17.5% 12.00 1,165,572 USD
2019-11-14 2019-11-12 B Purchase

Clarus IV-A, L.P.

Major owner
52,660 +17.5%
12.00
631,920 USD 		52,660 +17.5% 12.00 631,920 USD
2019-11-14 2019-11-12 B Purchase

Clarus IV-A, L.P.

Major owner
80,786 +17.5%
12.00
969,432 USD 		80,786 +17.5% 12.00 969,432 USD
2019-11-14 2019-11-12 B Purchase

Novo Holdings A/S

SEE REMARKS

Major owner
500,000 +17.2%
12.00
6,000,000 USD 		500,000 +17.2% 12.00 6,000,000 USD
2019-11-14 2019-11-12 B Purchase

Blackstone Clarus GP L.P.

Major owner
19,423 +17.5%
12.00
233,076 USD 		19,423 +17.5% 12.00 233,076 USD
2019-11-14 2019-11-12 B Purchase

Blackstone Clarus GP L.P.

Major owner
97,131 +17.5%
12.00
1,165,572 USD 		97,131 +17.5% 12.00 1,165,572 USD
2019-11-14 2019-11-12 B Purchase

Blackstone Clarus GP L.P.

Major owner
52,660 +17.5%
12.00
631,920 USD 		52,660 +17.5% 12.00 631,920 USD
2019-11-14 2019-11-12 B Purchase

Blackstone Clarus GP L.P.

Major owner
80,786 +17.5%
12.00
969,432 USD 		80,786 +17.5% 12.00 969,432 USD
2019-11-12 2019-11-12 B Purchase

Sofinnova Venture Partners IX, L.P.

Major owner
750,000 +32.1%
12.00
9,000,000 USD 		750,000 +32.1% 12.00 9,000,000 USD
2019-11-12 2019-11-12 B Purchase

New Enterprise Associates 14, L.P.

Major owner
416,666 +10.6%
12.00
4,999,992 USD 		416,666 +10.6% 12.00 4,999,992 USD
2019-11-12 2019-11-12 B Purchase

Novartis Bioventures Ltd

Major owner
250,000 +7.6%
12.00
3,000,000 USD 		250,000 +7.6% 12.00 3,000,000 USD